[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100648790":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":20,"locations":20,"responsibleParty":21,"collaborators":20,"id":23,"slug":24,"hasResults":25,"nctId":26,"briefTitle":27,"officialTitle":27,"acronym":28,"eligibilityCriteria":29,"healthyVolunteers":30,"sex":31,"minAge":32,"maxAge":33,"enrollmentInfo":34,"targetDuration":20,"studyType":37,"phases":38,"briefSummary":40,"conditions":41,"keywords":44,"overallStatus":45,"whyStopped":20,"lastUpdateSubmitDate":46,"lastUpdatePostDateStruct":47,"startDateStruct":50,"completionDateStruct":52,"leadSponsor":54,"locationsCount":20},{"fullName":5,"class":6},"Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"MONA imaging system","EXPERIMENTAL","acquisition mode with MONA imaging system",[13],"Device: MONA Imaging System",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","MONA Imaging System","acquisition mode with mona system",[9],null,{"type":22,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100648790","aoslo-imaging-for-the-study-of-cellular-alterations-in-retinal-neurodegeneration-100648790",false,"NCT07725055","AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration","RETION","Inclusion Criteria:\n\nPatients:\n\n* 100 subjects aged 10 to 79 years with a condition that may affect the inner retina (e.g., glaucoma, optic neuropathy, etc.)\n* 100 subjects aged 10 to 80 years with a condition that may affect the outer retina (e.g., AMD, retinitis pigmentosa, etc.)\n* Male or female\n* Covered by health insurance\n\nHealthy volunteers:\n\n* 30 subjects aged over 50 and under 80\n* 30 subjects aged over 18 and under 50\n* Male or female\n* Healthy subjects with no known condition that directly or indirectly affects the structure of the eye\n* Covered by health insurance\n\nExclusion Criteria:\n\nFor all subjects:\n\n* Inability to remain motionless on a standard ophthalmic chin rest. RETION\\_Protocol\\_v2.0 dated June 10, 2026\\_IDRCB: 2026-A00324-47 Page 10 of 44\n* Subjects taking medications or suffering from a medical condition that could interfere with the evaluations planned under the protocol;\n* Participants allergic to tropicamide in cases where pupil dilation is required. ☞ Wearing glasses or contact lenses to correct a refractive error is not considered an exclusion criterion.",true,"ALL","10 Years","79 Years",{"count":35,"type":36},260,"ESTIMATED","INTERVENTIONAL",[39],"NA","Primary objective:\n\n\\- Acquisition and analysis of images for non-medical purposes using the MONA IV system, an adaptive-optics-corrected scanning ophthalmoscope.\n\nSecondary objectives:\n\n* To measure the reproducibility of assessments;\n* To evaluate the detection of progressive changes.",[42,43],"Glaucoma Associated With Other Ocular Disorders","Retina Disorder",[28],"NOT_YET_RECRUITING","2026-07-21",{"date":48,"type":49},"2026-07-24","ACTUAL",{"date":51,"type":36},"2026-09",{"date":53,"type":36},"2030-04",{"name":5,"class":6}]